Drug Shortage Report for AMERGE
Report ID | 2581 |
Drug Identification Number | 02237821 |
Brand name | AMERGE |
Common or Proper name | Naratriptan hydrochloride tablet |
Company Name | GLAXOSMITHKLINE INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | NARATRIPTAN |
Strength(s) | 2.5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 6's |
ATC code | N02CC |
ATC description | ANTIMIGRAINE PREPARATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-03-02 |
Estimated end date | 2017-05-15 |
Actual end date | 2017-05-11 |
Shortage status | Resolved |
Updated date | 2017-05-12 |
Company comments | AMERGE® Tablet 1mg is available. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2017-05-12 | French | Compare |
v10 | 2017-05-12 | English | Compare |
v9 | 2017-05-12 | English | Compare |
v8 | 2017-05-10 | French | Compare |
v7 | 2017-05-10 | English | Compare |
v6 | 2017-03-24 | French | Compare |
v5 | 2017-03-24 | English | Compare |
v4 | 2017-03-22 | French | Compare |
v3 | 2017-03-22 | English | Compare |
v2 | 2017-03-14 | French | Compare |
v1 | 2017-03-14 | English | Compare |
Showing 1 to 11 of 11